Khalaf, Daniel J.
BC Cancer Agency
4 papers on CoChatORCID 0000-0001-6329-2678
Most cited papers
- Verified
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
Fonseca, N. M., Maurice-Dror, C., Herberts, C., Tu, W., Fan, W., Murtha, A. J., Kollmannsberger, C., Kwan, E. M., Parekh, K., Schönlau, E., et al. (2024) · Nature Communications
Prostate Cancer Treatment and ResearchCancer Genomics and Diagnostics
Cited by 145
- Verified
Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial
Annala, M., Fu, S., Bacon, J. V. W., Sipola, J., Iqbal, N., Ferrario, C., Ong, M., Wadhwa, D., Hotte, S. J., Lo, G., et al. (2021) · Annals of Oncology
Prostate Cancer Treatment and ResearchBone health and treatments
Cited by 73
- Verified
Platinum-based chemotherapy in triple-negative advanced breast cancer
Villarreal-Garza, C., Khalaf, D., Bouganim, N., Clemons, M., Peña-Curiel, O., Baez-Revueltas, B., Kiss, A., Kassam, F., Enright, K., Verma, S., et al. (2014) · Breast Cancer Research and Treatment
Breast Cancer Treatment StudiesCancer Treatment and Pharmacology
Cited by 33
- Verified
Finding the optimal treatment sequence in metastatic castration-resistant prostate cancer—a narrative review
Maurice Dror, C., Chi, K. N., & Khalaf, D. J. (2021) · Translational Andrology and Urology
Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free